专利号:WO-2015198349-A1 优先权日:2014-06-25 标 题 :A one pot synthesis of 3-substituted quinoline carboxylates and its derivatives 发明人:GADAKH SUNITA KHANDERAO; SUDALAI ARUMUGAM 权利人:COUNCIL SCIENT IND RES 摘要:The present invention provides a one pot, simple, cost effective and industrially feasible catalytic synthesis of quinolines or substituted quinolines from anilines with yield >80% yield. The present invention also discloses a process for the synthesis of oxolinic acid using quinolines with yield > 45%.
专利号:US-4021429-A 优先权日:1975-07-24 标 题 :Synthesis of ethylenically unsaturated compounds from esters or amides 发明人:SCHROCK RICHARD ROYCE 权利人:DU PONT 摘要:Certain hydrocarbylidene-niobium or -tantalum complexes react with esters or N,N-disubstituted amides to produce ethylenically unsaturated compounds. Exemplary is the reaction of trineopentyl(neopentylidene)tantalum with ethyl acetate to produce 2-ethoxy-4,4-dimethyl-2-pentene:
专利号:US-10227355-B2 优先权日:2015-02-03 标题:Quinoline derivatives and preparation thereof 发明人:BALARAMAN EKAMBARAM; MIDYA SIBA PRASAD; JAISWAL GARIMA 权利人:COUNCIL SCIENT IND RES 摘要:The patent discloses novel quinoline derivatives of formula (I), (Formula should be inserted here) and process for preparing the same. The compounds of formula (I) can be further used for the synthesis of Inhibitors like Kinase Tyrosine Inhibitors.
专利号:CN-101418005-B 优先权日:2008-12-22 标 题:A new method for the synthesis of prulifloxacin
专利号:CN-101418005-A 优先权日:2008-12-22 标题:A new method for the synthesis of prulifloxacin
专利号:US-2008200475-A1 优先权日:2005-03-28 标题:4-Piperazinothieno[2,3-D] Pyrimidine Compounds As Platelet Aggregation Inhibitors 发明人:ENNIS MICHAEL DALTON; KORTUM STEVEN WADE; TENBRINK RUTH ELIZABETH 权利人:PFIZER 摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: (I) wherein A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , A 7 , A 8 , X 4 , X 6 , R 2a , R x , R 4 , R 5 , and R 6 are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.